Targeting mitochondrial ion channels for cancer therapy
Pharmacological targeting of mitochondrial ion channels is emerging as a promising approach to eliminate cancer cells; as most of these channels are differentially expressed and/or regulated in cancer cells in comparison to healthy ones, this strategy may selectively eliminate the former. Perturbati...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Redox Biology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221323172031051X |
id |
doaj-5ec3b95f5f1a4baea7e050b37af05854 |
---|---|
record_format |
Article |
spelling |
doaj-5ec3b95f5f1a4baea7e050b37af058542021-04-26T05:55:30ZengElsevierRedox Biology2213-23172021-06-0142101846Targeting mitochondrial ion channels for cancer therapyIldiko Szabo0Mario Zoratti1Lucia Biasutto2Department of Biology, University of Padova, Italy; CNR Institute of Neurosciences, Padova, Italy; Corresponding author. viale G. Colombo 3, 35121, Padova, Italy.CNR Institute of Neurosciences, Padova, ItalyCNR Institute of Neurosciences, Padova, Italy; Department of Biomedical Sciences, University of Padova, ItalyPharmacological targeting of mitochondrial ion channels is emerging as a promising approach to eliminate cancer cells; as most of these channels are differentially expressed and/or regulated in cancer cells in comparison to healthy ones, this strategy may selectively eliminate the former. Perturbation of ion fluxes across the outer and inner membranes is linked to alterations of redox state, membrane potential and bioenergetic efficiency. This leads to indirect modulation of oxidative phosphorylation, which is/may be fundamental for both cancer and cancer stem cell survival. Furthermore, given the crucial contribution of mitochondria to intrinsic apoptosis, modulation of their ion channels leading to cytochrome c release may be of great advantage in case of resistance to drugs triggering apoptotic events upstream of the mitochondrial phase. In the present review, we give an overview of the known mitochondrial ion channels and of their modulators capable of killing cancer cells. In addition, we discuss state-of-the-art strategies using mitochondriotropic drugs or peptide-based approaches allowing a more efficient and selective targeting of mitochondrial ion channel-linked events.http://www.sciencedirect.com/science/article/pii/S221323172031051XMitochondriaIon channelsCancerDrug targetingChannel interactions |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ildiko Szabo Mario Zoratti Lucia Biasutto |
spellingShingle |
Ildiko Szabo Mario Zoratti Lucia Biasutto Targeting mitochondrial ion channels for cancer therapy Redox Biology Mitochondria Ion channels Cancer Drug targeting Channel interactions |
author_facet |
Ildiko Szabo Mario Zoratti Lucia Biasutto |
author_sort |
Ildiko Szabo |
title |
Targeting mitochondrial ion channels for cancer therapy |
title_short |
Targeting mitochondrial ion channels for cancer therapy |
title_full |
Targeting mitochondrial ion channels for cancer therapy |
title_fullStr |
Targeting mitochondrial ion channels for cancer therapy |
title_full_unstemmed |
Targeting mitochondrial ion channels for cancer therapy |
title_sort |
targeting mitochondrial ion channels for cancer therapy |
publisher |
Elsevier |
series |
Redox Biology |
issn |
2213-2317 |
publishDate |
2021-06-01 |
description |
Pharmacological targeting of mitochondrial ion channels is emerging as a promising approach to eliminate cancer cells; as most of these channels are differentially expressed and/or regulated in cancer cells in comparison to healthy ones, this strategy may selectively eliminate the former. Perturbation of ion fluxes across the outer and inner membranes is linked to alterations of redox state, membrane potential and bioenergetic efficiency. This leads to indirect modulation of oxidative phosphorylation, which is/may be fundamental for both cancer and cancer stem cell survival. Furthermore, given the crucial contribution of mitochondria to intrinsic apoptosis, modulation of their ion channels leading to cytochrome c release may be of great advantage in case of resistance to drugs triggering apoptotic events upstream of the mitochondrial phase. In the present review, we give an overview of the known mitochondrial ion channels and of their modulators capable of killing cancer cells. In addition, we discuss state-of-the-art strategies using mitochondriotropic drugs or peptide-based approaches allowing a more efficient and selective targeting of mitochondrial ion channel-linked events. |
topic |
Mitochondria Ion channels Cancer Drug targeting Channel interactions |
url |
http://www.sciencedirect.com/science/article/pii/S221323172031051X |
work_keys_str_mv |
AT ildikoszabo targetingmitochondrialionchannelsforcancertherapy AT mariozoratti targetingmitochondrialionchannelsforcancertherapy AT luciabiasutto targetingmitochondrialionchannelsforcancertherapy |
_version_ |
1721507931617230848 |